Lexeo Therapeutics, Inc. Common Stock (LXEO)
US$ 2.710.74%
Price Chart
Key Statistics
Market Cap
$ 147.73M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
513.82K
52W High
$ 19.50
52W Low
$ 1.45
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
3.1033
200-Day MA
7.1228
52 Week High
19.5
52 Week Low
1.45
About LXEO
Lexeo Therapeutics, Inc., a clinical stage genetic medicine company, focuses on hereditary and acquired diseases with high unmet need in the United States.
Employees
72
Headquarters
New York, NY
CEO
Mr. R. Nolan Townsend
Latest News
Why Lexeo Therapeutics (LXEO) Skyrocketed on Monday? - Yahoo Finance
2025-03-25 • Google News
$LXEO stock is up 17% today. Here's what we see in our data. - Nasdaq
5 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg